The Speaker
Wednesday, 17 July 2024 – 20:51
Photo by Number 10 Downing Street (CC BY-NC-ND 2.0)

Remdesivir: anti-viral drug to be available to selected UK Coronavirus patients

The Health Secretary Matt Hancock has announced the trial of anti-viral drug Remdesivir in the treatment of coronavirus.

Remdesivir is an anti-viral medicine that has previously been used against Ebola and other emerging diseases such as Mers.

Speaking during Tuesday’s daily Coronavirus press conference from Downing Street, Mr Hancock said the trial of the drug was “the biggest step forward in the treatment of coronavirus since the outbreak began”. Mr Hancock did though stress that the trial is at an early stage.

According to Mr Hancock, data has shown that the drug can cut recovery times by about four days. He said the drug is to be used on selected COVID-19 hospital patients who are most likely to benefit from using it. 

It is unknown how many patients will have access to the drug which is produced by Gilead Sciences.

According to the latest data, there are currently around 8,800 people in UK hospitals with the COVID-19 Coronavirus. The number of people to have died with the Coronavirus in the UK now stands at over 37,000 people.


Photo Credit: Pippa Fowles / No 10 Downing Street under licence (CC-BY-NC-ND 2.0)

Skip to content